Home » Authors » Anette Breindl

Articles by Anette Breindl

Apoptosis Gets Helping Hand From Blockage Of Bcl-2 Family

Nov. 11, 2004

By Anette Breindl

Dealing A Blow To Sepsis By Enlisting Neuro-Immune Axis

Nov. 10, 2004

By Anette Breindl

Dealing A Blow To Sepsis By Enlisting Neuro-Immune Axis

Nov. 10, 2004

By Anette Breindl

Starting With 'Smaller, Perfect Pieces' To Make Larger Genes

Nov. 8, 2004

By Anette Breindl

Starting With 'Smaller, Perfect Pieces' To Make Larger Genes

Nov. 8, 2004

By Anette Breindl

Chewing Up Inhibitors For Spinal Cord Injury Therapy

Nov. 4, 2004

By Anette Breindl

Chewing Up Inhibitors For Spinal Cord Injury Therapy

Nov. 4, 2004

By Anette Breindl

Looking Upstream For New Cancer Metastasis Insights

Nov. 2, 2004

By Anette Breindl

Looking Upstream For New Cancer Metastasis Insights

Nov. 2, 2004

By Anette Breindl

Effects Impressive, Mechanism Elusive For Endocannabinoids

Nov. 1, 2004

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....